Medinteract’s co-founder, Dr. John Dougherty and Dr. Alan Solomon from the University of Tennessee Medical Center, discuss the exciting research collaboration with Eli Lilly and Co. and the newly FDA-approved Amyvid which is used in the early diagnosis of mild cognitive impairment (MCI) and early Alzheimer’s disease.
http://www.knoxnews.com/news/2012/apr/15/doctors-collaborate-on-study-of-early-alzheimers/
Dr. Monica Crane, one of our advising physicians, recently spoke with WATE News about Pat Summitt’s impact on the Alzheimer’s community. http://www.wate.com/story/17538659/geriatric-specialist-discusses-pat-summitts-impact-on-the-alzheimers-community
Congratulations to Pat Summitt for being awarded the Presidential Medal of Freedom! She has been a role model to millions of people throughout her career and has recently become a key figure in the fight against Alzheimer’s. Her courage in publicly announcing her diagnosis has brought needed awareness to the disease and stressed the importance of early detection. As a member of the Knoxville community, we are excited to support Pat Summitt and her foundation in the fight against Alzheimer’s disease.
